Plasma clearance of an antibody-enzyme conjugate in ADEPT by monoclonal anti-enzyme: its effect on prodrug activation in vivo
- 1 December 1995
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 72 (6) , 1357-1363
- https://doi.org/10.1038/bjc.1995.515
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Application of monoclonal antibodies against cytosine deaminase for the in vivo clearance of a cytosine deaminase immunoconjugateBioconjugate Chemistry, 1993
- Optimisation of small-scale coupling of A5B7 monoclonal antibody to carboxypeptidase G2Journal of Immunological Methods, 1993
- Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft modelBritish Journal of Cancer, 1990
- Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2Journal of Medicinal Chemistry, 1990
- The effect of second antibody clearance on the distribution and dosimetry of radiolabelled anti-cea antibody in a human colonic tumor xenograft modelInternational Journal of Cancer, 1989
- A cytotoxic agent can be generated selectively at cancer sitesBritish Journal of Cancer, 1988
- Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate.Proceedings of the National Academy of Sciences, 1988
- Antibody directed enzymes revive anti-cancer prodrugs conceptBritish Journal of Cancer, 1987
- Biodistribution of Antibodies After Intraperitoneal or Intravenous Injection and Effect of Carbohydrate Modifications2JNCI Journal of the National Cancer Institute, 1987
- Purification and Properties of Carboxypeptidase G1Journal of Biological Chemistry, 1971